Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Point: Fluorescence in situ hybridization is the preferred approach over immunohistochemistry for determining HER2 status.

× No keyword cloud information.

4 in total

1. A magnetic micropore chip for rapid (<1 hour) unbiased circulating tumor cell isolation and in situ RNA analysis.

Authors: Jina Ko; Neha Bhagwat; Stephanie S Yee; Taylor Black; Colleen Redlinger; Janae Romeo; Mark O'Hara; Arjun Raj; Erica L Carpenter; Ben Z Stanger; David Issadore
Journal: Lab Chip Date: 2017-09-12 Impact factor: 6.799

2. A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections.

Authors: Hiroaki Nitta; Brian D Kelly; Mary Padilla; Nikolaus Wick; Patrick Brunhoeber; Isaac Bai; Shalini Singh; Jim Ranger-Moore; Chris Bieniarz; Hitoshi Tsuda; Thomas M Grogan
Journal: Diagn Pathol Date: 2012-05-30 Impact factor: 2.644

3. HER2 gene amplification in esophageal squamous cell carcinoma is less than in gastroesophageal junction and gastric adenocarcinoma.

Authors: Jun-Xing Huang; Kun Zhao; Mei Lin; Qi Wang; Wei Xiao; Mao-Song Lin; Hong Yu; Ping Chen; Rong-Yu Qian
Journal: Oncol Lett Date: 2013-05-15 Impact factor: 2.967

4. The human epidermal growth factor receptor 2 screening tests for breast cancer suggested by the new updated recommendation of the american society of clinical oncology/college of american pathologists will involve a rise of the in-situ hybridization tests for the European laboratories of pathology.

Authors: Christian Garbar; Aude-Marie Savoye; Corinne Mascaux; Eva Brabencova; Hervé Curé
Journal: ISRN Oncol Date: 2014-04-22

4 in total